Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
0(0%)
Results Posted
50%(3 trials)

Phase Distribution

Ph phase_1
3
50%
Ph phase_2
1
17%
Ph phase_3
2
33%

Phase Distribution

3

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
3(50.0%)
Phase 2Efficacy & side effects
1(16.7%)
Phase 3Large-scale testing
2(33.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Completed(6)

Detailed Status

Completed6

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 13 (50.0%)
Phase 21 (16.7%)
Phase 32 (33.3%)

Trials by Status

completed6100%

Recent Activity

0 active trials
Showing 5 of 6
completedphase_3

Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients

NCT02109562
completedphase_2

Multiple Ascending Dose Study of the Safety, Tolerability, Pharmacokinetic/Efficacy

NCT01677377
completedphase_3

Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia

NCT02203838
completedphase_1

PK, Safety, and Tolerability Study of RBP-7000 of Different Molecular Weight Polymer in Subjects With Schizophrenia

NCT02687984
completedphase_1

Single Ascending Dose Study of RBP-7000

NCT02768649
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT02109562Phase 3

Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients

Completed
NCT01677377Phase 2

Multiple Ascending Dose Study of the Safety, Tolerability, Pharmacokinetic/Efficacy

Completed
NCT02203838Phase 3

Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia

Completed
NCT02687984Phase 1

PK, Safety, and Tolerability Study of RBP-7000 of Different Molecular Weight Polymer in Subjects With Schizophrenia

Completed
NCT02768649Phase 1

Single Ascending Dose Study of RBP-7000

Completed
NCT02765555Phase 1

First in Man Study of Safety, Tolerability and PK Profile of RBP-7000

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6